Merck CEO Rob Davis Talks Winrevair Approval

Merck CEO Rob Davis joins Bloomberg's Jonathan Ferro and Lisa Abramowicz to discuss the approval of the company's treatment for high blood pressure called Winrevair. 

See omnystudio.com/listener for privacy information.